Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
HLN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.32

Margin Of Safety %

-8

Put/Call OI Ratio

0.11

EPS Next Q Diff

EPS Last/This Y

0.05

EPS This/Next Y

0.06

Price

9.8

Target Price

11.02

Analyst Recom

2.12

Performance Q

2.73

Upside

10.1%

Beta

0.1

Ticker: HLN




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-06-29HLN9.330.090.002611
2026-06-30HLN9.320.090.002623
2026-07-01HLN9.40.090.002627
2026-07-02HLN9.810.090.002639
2026-07-06HLN9.730.080.502681
2026-07-07HLN9.840.080.002683
2026-07-08HLN9.750.100.002402
2026-07-09HLN9.720.100.802400
2026-07-10HLN9.770.100.002409
2026-07-13HLN9.860.100.462406
2026-07-14HLN9.70.103.002414
2026-07-15HLN9.740.102.252418
2026-07-16HLN10.120.110.212431
2026-07-17HLN10.10.110.462478
2026-07-20HLN10.050.100.012223
2026-07-21HLN9.920.11999.992225
2026-07-22HLN9.850.111.082228
2026-07-23HLN9.710.110.132250
2026-07-24HLN9.80.110.062237
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-06-29HLN9.32- - -
2026-06-30HLN9.32- - -
2026-07-01HLN9.40- -139.50.55
2026-07-02HLN9.81- -53.30.55
2026-07-06HLN9.73- -209.20.55
2026-07-08HLN9.75- -238.90.55
2026-07-09HLN9.73- -230.90.55
2026-07-10HLN9.77- -220.50.55
2026-07-13HLN9.86- -185.10.55
2026-07-14HLN9.70- -225.50.55
2026-07-15HLN9.75- -203.20.55
2026-07-16HLN10.12- -98.40.55
2026-07-17HLN10.10- -181.50.55
2026-07-20HLN10.05- -217.70.55
2026-07-21HLN9.92- -233.80.55
2026-07-22HLN9.85- -233.90.55
2026-07-23HLN9.71- -252.70.55
2026-07-24HLN9.80- -200.70.55
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-06-29HLN0-9.580.34
2026-06-30HLN0-9.580.34
2026-07-01HLN0-9.580.34
2026-07-02HLN0-9.580.34
2026-07-06HLN0-9.760.34
2026-07-07HLN0-9.760.34
2026-07-08HLN0-9.760.34
2026-07-09HLN0-9.760.34
2026-07-10HLN0-9.760.34
2026-07-13HLN0-9.680.32
2026-07-14HLN0-9.680.32
2026-07-15HLN0-9.680.32
2026-07-16HLN0-9.680.32
2026-07-17HLN0-9.680.32
2026-07-20HLN022.700.32
2026-07-21HLN022.700.32
2026-07-22HLN022.700.32
2026-07-23HLN022.700.32
2026-07-24HLN022.700.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

22.7

Beta

0.1

Average Sales Estimate Current Quarter

2856

Average Sales Estimate Next Quarter

2742

Fair Value

9.04

Quality Score

85

Growth Score

60

Sentiment Score

26

Actual DrawDown %

14.2

Max Drawdown 5-Year %

Target Price

11.02

P/E

20.1

Forward P/E

16.22

PEG

1.79

P/S

2.97

P/B

1.97

P/Free Cash Flow

15.98

EPS

0.49

Average EPS Est. Cur. Y​

0.55

EPS Next Y. (Est.)

0.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.12

Relative Volume

1.24

Return on Equity vs Sector %

-17.2

Return on Equity vs Industry %

3.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

-200.7
HLN Healthcare
$9.79
📉
Swing / Pullback
Buy the dip on strong trends
38 /100
WEAK
Trend
0/20
Pullback
10/25
Volume
4/15
Valuation
15/20
TP/AR
1/10
Options
8/10
RSI
55.2
Range 1M
58.1%
Sup Dist
1.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
39 /100
WEAK
Momentum
2/25
Growth
15/30
Estimates
6/20
Inst/Vol
8/15
Options
8/10
EPS Yr
8.4%
EPS NY
9.5%
52W%
44.3%
💎
Long-Term Value
Quality companies, undervalued
35 /100
WEAK
🟡 HOLD +18.8% upside
Quality
14/30
Valuation
5/30
Growth
11/25
Stability
4/10
LT Trend
1/5
Upside
+18.8%
Quality
85
MoS
-8%
HLN — P/E HistoricalDrug Manufacturers - Specialty & Generic
Haleon plc
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 24535
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
HLN

Latest News

Caricamento notizie per HLN
stock quote shares HLN – Haleon plcHLN Stock Price stock today
news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025
marketwatch HLN – Haleon plcHLN yahoo finance google finance
stock history HLN – Haleon plcHLN invest stock market
stock prices HLN premarket after hours
ticker HLN fair value insiders trading